Discover 2024's AI Investment Front-Runners! 🌟 (ad) |
Are you eager to know which AI stocks will dominate in 2024? We've pinpointed the top 3 and are thrilled to share our findings with you! Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Claim Your Complimentary Report Today |
|
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (ad) |
|
Apple Inc. (AAPL) Amazon.com, Inc. (AMZN) Barker Minerals Ltd (BML) - No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today
Meta Platforms, Inc. (META) Microsoft Co. (MSFT) - Alerus Financial (NASDAQ:ALRS) was upgraded by analysts at Hovde Group from a "market perform" rating to an "outperform" rating. They now have a $23.00 price target on the stock, up previously from $21.00. This represents a 17.1% upside from the current price of $19.64.
- B&G Foods (NYSE:BGS) was upgraded by analysts at Piper Sandler from an "underweight" rating to a "neutral" rating. They now have a $9.00 price target on the stock. This represents a 5.5% downside from the current price of $9.52.
- Coupang (NYSE:CPNG) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $26.00 price target on the stock. This represents a 13.0% upside from the current price of $23.00.
- Coterra Energy (NYSE:CTRA) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $27.00. This represents a 24.6% upside from the current price of $28.08.
- Extreme Networks (NASDAQ:EXTR) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock. This represents a 17.4% upside from the current price of $11.92.
- GoodRx (NASDAQ:GDRX) was upgraded by analysts at Raymond James from a "market perform" rating to an "outperform" rating. They now have a $10.00 price target on the stock. This represents a 22.7% upside from the current price of $8.15.
- Hut 8 (NASDAQ:HUT) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock. This represents a 35.6% upside from the current price of $8.85.
- Intel (NASDAQ:INTC) was upgraded by analysts at Wolfe Research from an "underperform" rating to a "peer perform" rating.The current price is $31.71.
- 3M (NYSE:MMM) was upgraded by analysts at Vertical Research from a "hold" rating to a "buy" rating. They now have a $140.00 price target on the stock. This represents a 33.5% upside from the current price of $104.85.
- Prime Medicine (NYSE:PRME) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $10.00 price target on the stock. This represents a 43.9% upside from the current price of $6.95.
- Trupanion (NASDAQ:TRUP) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $49.00 price target on the stock, up previously from $35.00. This represents a 48.8% upside from the current price of $32.93.
- Wayfair (NYSE:W) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $83.00 price target on the stock. This represents a 20.3% upside from the current price of $68.99.
- Energous (NASDAQ:WATT) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating. They now have a $2.00 price target on the stock. This represents a 29.1% upside from the current price of $1.55.
- ZimVie (NASDAQ:ZIMV) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock. This represents a 17.8% upside from the current price of $16.98.
- View today's most recent analysts' upgrades at MarketBeat.com
Explore Top Picks for Investors in 2024! (ad) |
Welcome to a promising year ahead! We're excited to share our carefully curated guide, "Top 9 Stocks to Watch," designed to enhance your investment strategy in 2024. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Access Your Exclusive Report Now |
|
- Camtek (NASDAQ:CAMT) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating.The current price is $99.08.
- Cirrus Logic (NASDAQ:CRUS) was downgraded by analysts at Benchmark Co. from a "buy" rating to a "hold" rating.The current price is $111.96.
- Dada Nexus (NASDAQ:DADA) was downgraded by analysts at Daiwa Capital Markets from a "buy" rating to a "neutral" rating.The current price is $1.87.
- EOG Resources (NYSE:EOG) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $136.00 price target on the stock, down previously from $163.00. This represents a 5.9% upside from the current price of $128.47.
- Occidental Petroleum (NYSE:OXY) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $69.00 price target on the stock, down previously from $84.00. This represents a 9.7% upside from the current price of $62.91.
- Treace Medical Concepts (NASDAQ:TMCI) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $6.50 price target on the stock, down previously from $16.00. This represents a 12.3% upside from the current price of $5.79.
- Under Armour (NYSE:UAA) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.The current price is $6.87.
- Valero Energy (NYSE:VLO) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $158.05.
- View today's most recent analysts' downgrades at MarketBeat.com
The Greatest Bull Market in Crypto History… (ad) |
Juan Villaverde is no ordinary crypto trader.
His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin …
It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.
Here's what our expert says you should buy before April 14. |
|
- Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $4.50 price target on the stock. This represents a 148.6% upside from the current price of $1.81.
- Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $4.50 price target on the stock. This represents a 148.6% upside from the current price of $1.81.
- Dianthus Therapeutics (NASDAQ:DNTH) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $40.00 price target on the stock. This represents a 47.3% upside from the current price of $27.16.
- Quaker Chemical (NYSE:KWR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $220.00 price target on the stock. This represents a 17.6% upside from the current price of $187.02.
- Nikola (NASDAQ:NKLA) is now covered by analysts at Bryan, Garnier & Co. They set a "buy" rating and a $1.00 price target on the stock. This represents a 80.5% upside from the current price of $0.55.
- SharkNinja (NYSE:SN) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $90.00 price target on the stock.
- TScan Therapeutics (NASDAQ:TCRX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $12.00 price target on the stock. This represents a 32.9% upside from the current price of $9.03.
- Truist Financial (NYSE:TFC) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $43.00 price target on the stock. This represents a 7.0% upside from the current price of $40.19.
- Texas Instruments (NASDAQ:TXN) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $150.00 price target on the stock. This represents a 23.2% downside from the current price of $195.19.
- View today's most recent analysts' new coverage at MarketBeat.com
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL |
|
Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW |
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: Trump's Former Wingman Bets Big on AI |
|
No comments:
Post a Comment